shenzhen mindray bio-medical electronics patient monitor epm 101215
its science & medical pte ltd - general hospital - the epm series patient monitors (10/12/15) are intended to be used for monitoring, displaying, reviewing, storing, alarming and transferring of multiple physiological parameters including ecg, arrhythmia detection, st segment analysis, qt/qtc monitoring, and heart rate, respiration, temperature, pulse oxygen saturation, pulse rate, non-invasive blood pressure, invasive blood pressure, cardiac output, carbon dioxide, oxygen, anesthetic gas and bispectral index. the monitor also provides an interpretation of resting 12-lead ecg. this monitor is to be used in healthcare facilities by clinical professionals or under their guidance. it is not intended for helicopter transport, hospital ambulance, or home use.
shenzhen mindray bio-medical electronics patient monitor epm 10m12m15m
its science & medical pte ltd - general hospital - the epm series patient monitors (10m/12m/15m) are intended to be used for monitoring, displaying, reviewing, storing, alarming and transferring of multiple physiological parameters including ecg, arrhythmia detection, st segment analysis, qt/qtc monitoring, and heart rate, respiration, temperature, pulse oxygen saturation, pulse rate, non-invasive blood pressure, invasive blood pressure, cardiac output, carbon dioxide, oxygen, anesthetic gas and bispectral index. the monitor also provides an interpretation of resting 12-lead ecg. this monitor is to be used in healthcare facilities by clinical professionals or under their guidance. it is not intended for helicopter transport, hospital ambulance, or home use.
tepmetko 225mg tablets
merck serono ltd - tepotinib hydrochloride - tablet - 225mg
epm 10 tab
grandix - enalapril - tab - 10mg - 10
epm 10/10 tab
grandix - enalapril - tab - 2.5/5;mg - 10/10
penicillin v potassium tablet, film coated
proficient rx lp - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of penicillin v potassium and other antibacterial drugs, penicillin v potassium should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. penicillin v potassium tablets are indicated in the treatment of mild to moderately severe infections due to penicillin g-sensitive microorganisms. therapy should be guided by bacteriologic studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following inf
rometri 750 wg herbicide
rotam agrochemical co., ltd. - metribuzin - water dispersible granule - metribuzin triazine-triazinones active 750.0 g/kg - herbicide
topiramate capsule coated pellets
american health packaging - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate 25 mg
marquis antiprotozoal- ponazuril paste
merial, inc. - ponazuril (unii: jpw84as66u) (ponazuril - unii:jpw84as66u) - ponazuril 150 mg in 1 g - indications: marquis is indicated for the treatment of equine protozoal myeloencephalitis (epm) caused by sarcocystis neurona .
rebalance antiprotozoal- sulfadiazine and pyrimethamine suspension
pegasus laboratories, inc - sulfadiazine sodium (unii: 84cs1p306f) (sulfadiazine - unii:0n7609k889), pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - sulfadiazine 250 mg in 1 ml - rebalance antiprotozoal oral suspension is indicated for the treatment of horses with equine protozoal myeloencephalitis (epm) caused by sarcocystis neurona . the use of rebalance antiprotozoal oral suspension in contraindicated in horses with known hypersensitivity to sulfonamide drugs or pyrimethamine.